TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

LINDEN ADVISORS LP's Holding History (CIK: 0001279396)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 85,562,000 Value ($000) $122,037 Avg Close — Range —
Q3 2025
Shares 90,506,000 Value ($000) $102,277 Avg Close — Range —
Q2 2025
Shares 94,068,000 Value ($000) $89,728 Avg Close — Range —
Q1 2025
Shares 94,068,000 Value ($000) $93,792 Avg Close — Range —
Q4 2024
Shares 62,068,000 Value ($000) $58,663 Avg Close — Range —
Q3 2024
Shares 27,743,000 Value ($000) $23,992 Avg Close — Range —
Q2 2024
Shares 4,243,000 Value ($000) $2,744 Avg Close — Range —
Q1 2024
Shares 2,993,000 Value ($000) $1,897 Avg Close — Range —
Q4 2023
Shares 1,493,000 Value ($000) $987 Avg Close — Range —
Q3 2023
Shares 1,493,000 Value ($000) $963 Avg Close — Range —
Q2 2023
Shares 13,993,000 Value ($000) $11,366 Avg Close — Range —
Q1 2023
Shares 28,993,000 Value ($000) $28,511 Avg Close — Range —
Q1 2022
Shares 20,000,000 Value ($000) $21,281 Avg Close — Range —